Previous close | 3.2000 |
Open | 3.2000 |
Bid | 3.0000 |
Ask | 3.6000 |
Strike | 42.00 |
Expiry date | 2023-01-20 |
Day's range | 3.2000 - 3.2000 |
Contract range | N/A |
Volume | |
Open interest | 3.42k |
Boston Scientific's (BSX) latest acquisition will add the FDA-approved GEM technology to its interventional oncology and embolization portfolio.
Novartis, Duke Energy, Boston Scientific, Norfolk Southern and Cadence Design Systems are part of Zacks top Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Duke Energy Corporation (DUK), and Boston Scientific Corporation (BSX).